Paul R. Fonteyne's Net Worth
$583 Thousand
Who is Paul R. Fonteyne?
Paul R. Fonteyne does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Amylyx Pharmaceuticals, Inc., resTORbio, Inc., COVETRUS, INC., Apellis Pharmaceuticals, Inc., GELESIS HOLDINGS, INC., and AMAG PHARMACEUTICALS, INC..
SEC CIK
Paul R. Fonteyne's CIK is 0001727550
Past Insider Trading and Trends
2022 was Paul R. Fonteyne's most active year for acquiring shares with 8 total transactions. Paul R. Fonteyne's most active month to acquire stocks was the month of December. 2020 was Paul R. Fonteyne's most active year for disposing of shares, totalling 4 transactions. Paul R. Fonteyne's most active month to dispose stocks was the month of October. 2020 saw Paul R. Fonteyne paying a total of $159,034.00 for 88,472 shares, this is the most they've acquired in one year. In 2020 Paul R. Fonteyne cashed out on 51,417 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Amylyx Pharmaceuticals, Inc. (AMLX) Snapshot price: $15.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
∞
| 3.95K |
$19.00 | $74,993.00 | 3.95K |
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
resTORbio, Inc. (ACET) Snapshot price: $3.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
COVETRUS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.28K |
—
|
—
|
0
|
Oct 13
| |||
Form 4
| +165.50% | 8.28K |
—
|
—
| 13.28K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
∞
| 5K |
$23.24 | $116,200.00 | 5K |
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Apellis Pharmaceuticals, Inc. (APLS) Snapshot price: $66.64
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.51% | 3.34K |
—
|
—
| 16.44K |
Jan 1
| |||
Form 4
| +41.90% | 3.87K |
—
|
—
| 13.1K |
Jan 1
| |||
Form 4
| +84.60% | 4.23K |
—
|
—
| 9.23K |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
∞
| 5K |
$31.81 | $159,034.00 | 5K |
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GELESIS HOLDINGS, INC. (GLSHQ) Snapshot price: $0.0021
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 53.83K |
—
|
—
| 53.83K |
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||